These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 25938227)

  • 1. Risk of Active Tuberculosis in HIV-Infected Patients in Taiwan with Free Access to HIV Care and a Positive T-Spot.TB Test.
    Sun HY; Hsueh PR; Liu WC; Su YC; Chang SY; Hung CC; Chang SC
    PLoS One; 2015; 10(5):e0125260. PubMed ID: 25938227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latent Tuberculosis Infection Screening and 2-Year Outcome in Antiretroviral-Naive HIV-Infected Patients in a Low-Prevalence Country.
    Bourgarit A; Baron G; Breton G; Tattevin P; Katlama C; Allavena C; Campa P; Ravaud P; Lortholary O; Carcelain G;
    Ann Am Thorac Soc; 2015 Aug; 12(8):1138-45. PubMed ID: 26213798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of tuberculosis in HIV-infected patients receiving HAART: interaction between TST and CD4 count.
    Martín-Echevarria E; Rodríguez-Zapata M; Torralba M; Fernández JM; Moreno A; Casado JL; Dronda F; Pérez-Elías MJ; Navas E; Moreno S
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1347-52. PubMed ID: 22283893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country.
    Stephan C; Wolf T; Goetsch U; Bellinger O; Nisius G; Oremek G; Rakus Z; Gottschalk R; Stark S; Brodt HR; Staszewski S
    AIDS; 2008 Nov; 22(18):2471-9. PubMed ID: 19005270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission.
    Elzi L; Schlegel M; Weber R; Hirschel B; Cavassini M; Schmid P; Bernasconi E; Rickenbach M; Furrer H;
    Clin Infect Dis; 2007 Jan; 44(1):94-102. PubMed ID: 17143823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low prevalence of positive interferon-gamma tests in HIV-positive long-term immigrants in Norway.
    Pullar ND; Steinum H; Tonby K; Heggelund L; Leiva RA; Ofstad R; Bruun JN; Dyrhol-Riise AM
    Int J Tuberc Lung Dis; 2014 Feb; 18(2):180-7. PubMed ID: 24429310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of tuberculosis in human immunodeficiency virus infected patients receiving antiretroviral therapy.
    Martín-Echevarria E; Serrano-Villar S; Sainz T; Moreno A; Casado JL; Dronda F; Elías MJ; Navas E; Zapata MR; Moreno S
    Int J Tuberc Lung Dis; 2014 Sep; 18(9):1080-4. PubMed ID: 25189556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological recovery in tuberculosis/HIV co-infected patients on antiretroviral therapy: implication for tuberculosis preventive therapy.
    Karo B; Krause G; Castell S; Kollan C; Hamouda O; Haas W;
    BMC Infect Dis; 2017 Jul; 17(1):517. PubMed ID: 28743248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-SPOT.TB in the diagnosis of active tuberculosis among HIV-infected patients with advanced immunodeficiency.
    Chen J; Sun J; Zhang R; Liu L; Zheng Y; Shen Y; Wang Z; Sun F; Li L; Lu H
    AIDS Res Hum Retroviruses; 2011 Mar; 27(3):289-94. PubMed ID: 20977360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Clinical Algorithm to Identify HIV Patients at High Risk for Incident Active Tuberculosis: A Prospective 5-Year Cohort Study.
    Lee SS; Lin HH; Tsai HC; Su IJ; Yang CH; Sun HY; Hung CC; Sy CL; Wu KS; Chen JK; Chen YS; Fang CT
    PLoS One; 2015; 10(8):e0135801. PubMed ID: 26280669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of tuberculosis in HIV-infected patients in Spain: the impact of treatment for LTBI.
    Martínez-Pino I; Sambeat MA; Lacalle-Remigio JR; Domingo P;
    Int J Tuberc Lung Dis; 2013 Dec; 17(12):1545-51. PubMed ID: 24200266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)-infected individuals enrolled with suspected active tuberculosis: a pilot study.
    Vincenti D; Carrara S; Butera O; Bizzoni F; Casetti R; Girardi E; Goletti D
    Clin Exp Immunol; 2007 Oct; 150(1):91-8. PubMed ID: 17680823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of interferon-gamma release assays for postpartum active tuberculosis in HIV-1-infected women.
    Jonnalagadda SR; Brown E; Lohman-Payne B; Wamalwa D; Farquhar C; John-Stewart GC
    Int J Tuberc Lung Dis; 2013 Dec; 17(12):1552-7. PubMed ID: 24200267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of tuberculosis and mycobacteriosis among HIV-infected patients--clinical and epidemiological analysis of patients from north-eastern Poland.
    Łucejko M; Grzeszczuk A; Rogalska M; Flisiak R
    Pneumonol Alergol Pol; 2013; 81(6):502-10. PubMed ID: 24142779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002-2005.
    Gupta A; Nayak U; Ram M; Bhosale R; Patil S; Basavraj A; Kakrani A; Philip S; Desai D; Sastry J; Bollinger RC;
    Clin Infect Dis; 2007 Jul; 45(2):241-9. PubMed ID: 17578786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of the risk of tuberculosis among HIV-infected patients.
    Guelar A; Gatell JM; Verdejo J; Podzamczer D; Lozano L; Aznar E; Miró JM; Mallolas J; Zamora L; González J
    AIDS; 1993 Oct; 7(10):1345-9. PubMed ID: 8267907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculin skin test conversion among HIV patients on antiretroviral therapy in Uganda.
    Kirenga BJ; Worodria W; Massinga-Loembe M; Nalwoga T; Manabe YC; Kestens L; Colebunders R; Mayanja-Kizza H
    Int J Tuberc Lung Dis; 2013 Mar; 17(3):336-41. PubMed ID: 23407223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk assessment of tuberculosis in immunocompromised patients. A TBNET study.
    Sester M; van Leth F; Bruchfeld J; Bumbacea D; Cirillo DM; Dilektasli AG; Domínguez J; Duarte R; Ernst M; Eyuboglu FO; Gerogianni I; Girardi E; Goletti D; Janssens JP; Julander I; Lange B; Latorre I; Losi M; Markova R; Matteelli A; Milburn H; Ravn P; Scholman T; Soccal PM; Straub M; Wagner D; Wolf T; Yalcin A; Lange C;
    Am J Respir Crit Care Med; 2014 Nov; 190(10):1168-76. PubMed ID: 25303140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+ cell count responses to antiretroviral therapy are not impaired in HIV-infected individuals with tuberculosis co-infection.
    Gupta RK; Brown AE; Zenner D; Rice B; Yin Z; Thomas HL; Pozniak A; Abubakar I; Delpech V; Lipman M
    AIDS; 2015 Jul; 29(11):1363-8. PubMed ID: 26091298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.